Rivaroxaban reduced blood clots and related death in cancer patients
Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly ...
Dec 4, 2018
0
0